Abstract The SARs-CoV-2 (COVID-19) virus, which was first identified in December 2019, in
Wuhan China, is a respiratory virus that induces respiratory distress and a systemic …

While classic vaccines have proved greatly efficacious in eliminating serious infectious
diseases, innovative vaccine platforms open a new pathway to overcome dangerous …

Photodynamic therapy (PDT) of cancer is a clinically approved, minimally invasive
therapeutic approach, combining PDT drug (photosensitizer, PS), molecular oxygen and …

To assess the biology of the lethal endpoint in patients with SARS-CoV-2 infection, we
compared the transcriptional response to the virus in patients who survived or died during …

In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) caused the outbreak of coronavirus disease 2019 (COVID-19), and the resulting …

To date, more than 100 million people worldwide have recovered from COVID-19.
Unfortunately, although the virus is eradicated in such patients, fibrotic irreversible interstitial …

With the expansion of research volume, coinciding with the age of the internet, the retraction
of published papers from scientific journals has become crucial to preserving scientific …

Auranofin is an FDA-approved disease-modifying anti-rheumatic drug that has been used
for decades for treatment of rheumatoid arthritis. This gold (I) compound has anti …

Background: Coronavirus disease 2019 (COVID-19) is a global pandemic that has caused
more than 600 million cases and over six million deaths worldwide. Despite the availability …

COVID‑19, a new human respiratory disease that has killed nearly 3 million people in a year
since the start of the pandemic, is a global public health challenge. Its infectious agent …